Influence of body mass on predicted values of static hyperinflation in COPD

Peter Alter, Klaus F Rabe, Holger Schulz, Claus F Vogelmeier, Rudolf A Jörres, Peter Alter, Klaus F Rabe, Holger Schulz, Claus F Vogelmeier, Rudolf A Jörres

Abstract

Introduction: For interpretation of body plethysmographic static hyperinflation, reference values are of crucial importance. Earliest reference values have been published by the European Coal and Steel Community (ECSC) and are based on sex, body height and age as predictors. As obesity can lead to a reduction of functional residual capacity (FRC) in lung-healthy subjects, more recent approaches included body weight or body surface area. This raises the question whether these models are appropriate in patients with COPD-induced hyperinflation.

Method: Several FRC prediction models and their relation to body weight were analyzed in 1513 patients with stable COPD (mean [SD] age: 64.5 [8.2] years; GOLD grades 1-4: 219/722/484/88), a subset of the multicenter COPD and Systemic Consequences - Comorbidities Network cohort.

Results: Absolute values of FRC were inversely related to body mass index (p<0.001). Applying the ECSC equations to calculate predicted values, this pattern was maintained (p<0.001). By contrast, an inverted, ie, positive, relation occurred when using equations that include body weight or surface area (p<0.001). The present analysis confirmed the inverse relation of body mass and FRC in COPD, resulting from a restrictive ventilatory pattern by diaphragm elevation and decreased chest wall compliance in obesity. The weight influence in the prediction models, as obtained from lung-healthy controls, appears to lead to an overcorrection and consequently to an inappropriate overestimation of hyperinflation as indicated by FRC %predicted in COPD.

Conclusion: It is concluded that models not including body weight as predictor, like the classical ECSC equations, could be superior in the interpretation of FRC in COPD.

Keywords: COPD; body mass; body plethysmography; functional residual capacity; static hyperinflation.

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Scatter diagrams and regression lines (p<0.001 each) of static lung volume (FRC) versus BMI in terms of absolute values (A) and %predicted by ECSC (B) based on body height and age, as %predicted by Cordero et al (C), Koch et al (D) and Garcia-Rio et al (E) including body weight as predictor; in addition, as %predicted by Garcia-Rio et al without weight-related factors (F). Abbreviations: BMI, body mass index; ECSC, European Coal and Steel Community; FRC, functional residual capacity.

References

    1. Criée CP, Sorichter S, Smith HJ, et al. Body plethysmography – its principles and clinical use. Respir Med. 2011;105(7):959–971.
    1. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5–40.
    1. Cordero PJ, Morales P, Benlloch E, Miravet L, Cebrian J. Static lung volumes: reference values from a Latin population of Spanish descent. Respiration. 1999;66(3):242–250.
    1. Koch B, Friedrich N, Völzke H, et al. Static lung volumes and airway resistance reference values in healthy adults. Respirology. 2013;18(1):170–178.
    1. Garcia-Rio F, Dorgham A, Pino JM, Villasante C, Garcia-Quero C, Alvarez-Sala R. Lung volume reference values for women and men 65 to 85 years of age. Am J Respir Crit Care Med. 2009;180(11):1083–1091.
    1. Langer D, Ciavaglia CE, Neder JA, Webb KA, O’Donnell DE. Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment. Expert Rev Respir Med. 2014;8(6):731–749.
    1. Karch A, Vogelmeier C, Welte T, et al. The German COPD cohort COSYCONET: aims, methods and descriptive analysis of the study population at baseline. Respir Med. 2016;114:27–37.
    1. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–522.
    1. Vogelmeier C, Buhl R, Criée CP, et al. Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD) [Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin] Pneumologie. 2007;61(5):e1–e40. German.
    1. Quanjer PH, Stanojevic S, Cole TJ, et al. ERS Global Lung Function Initiative Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343.
    1. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3) pii:1700214.
    1. Ladosky W, Botelho MA, Albuquerque JP., Jr Chest mechanics in morbidly obese non-hypoventilated patients. Respir Med. 2001;95(4):281–286.
    1. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir. 1983;19(Suppl 5):1–95.

Source: PubMed

Подписаться